LON:AGR - Assura Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: GBX 83.83
  • Forecasted Upside: 8.66 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
GBX 77.15
▼ -0.4 (-0.52%)

This chart shows the closing price for AGR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Assura Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AGR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AGR

Analyst Price Target is GBX 83.83
▲ +8.66% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Assura in the last 3 months. The average price target is GBX 83.83, with a high forecast of GBX 90 and a low forecast of GBX 75. The average price target represents a 8.66% upside from the last price of GBX 77.15.

This chart shows the closing price for AGR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 6 contributing investment analysts is to hold stock in Assura. This rating has held steady since March 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
2/2/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
5/2/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/31/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/29/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/27/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/27/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
6/26/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
7/26/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/19/2021Berenberg BankBoost Price TargetHoldGBX 75 ➝ GBX 80
5/18/2021Peel HuntReiterated RatingAddGBX 85
5/18/2021Peel HuntReiterated RatingAddGBX 85
5/18/2021Liberum CapitalReiterated RatingHoldGBX 75
5/18/2021Numis SecuritiesReiterated RatingAddGBX 88
2/17/2021Jefferies Financial GroupBoost Price TargetBuyGBX 87 ➝ GBX 90
7/7/2020Peel HuntReiterated RatingAdd
7/7/2020Liberum CapitalReiterated RatingHold
6/2/2020Liberum CapitalReiterated RatingHoldGBX 80
5/25/2020Berenberg BankBoost Price TargetHoldGBX 75 ➝ GBX 80
5/25/2020Jefferies Financial GroupLower Price TargetBuyGBX 94 ➝ GBX 87
5/22/2020BarclaysReiterated RatingOverweight
5/21/2020Peel HuntReiterated RatingAdd
5/21/2020Liberum CapitalReiterated RatingHold
5/6/2020Berenberg BankDowngradeHold
5/6/2020Peel HuntUpgradeAddGBX 80 ➝ GBX 85
4/15/2020BarclaysBoost Price TargetOverweightGBX 81 ➝ GBX 85
4/9/2020Berenberg BankDowngradeHold
4/8/2020JPMorgan Chase & Co.Boost Price TargetOverweightGBX 81 ➝ GBX 83
4/7/2020Liberum CapitalReiterated RatingHold
4/2/2020Jefferies Financial GroupBoost Price TargetBuyGBX 79 ➝ GBX 94
4/2/2020Peel HuntReiterated RatingHold
3/13/2020JPMorgan Chase & Co.Reiterated RatingOverweight
3/11/2020Berenberg BankReiterated RatingHold
2/11/2020Peel HuntReiterated RatingHold
1/27/2020Liberum CapitalBoost Price TargetHoldGBX 76 ➝ GBX 80
1/16/2020JPMorgan Chase & Co.Boost Price TargetOverweightGBX 79 ➝ GBX 81
1/13/2020Peel HuntReiterated RatingHold
1/13/2020Liberum CapitalReiterated RatingHold
1/7/2020Peel HuntReiterated RatingHold
12/17/2019Peel HuntBoost Price TargetHoldGBX 62 ➝ GBX 80
12/13/2019Jefferies Financial GroupReiterated RatingBuy
12/6/2019Liberum CapitalReiterated RatingHold
12/3/2019BarclaysInitiated CoverageOverweightGBX 81
12/3/2019Peel HuntReiterated RatingHold
11/29/2019Berenberg BankInitiated CoverageHoldGBX 75
11/26/2019Peel HuntReiterated RatingHold
11/12/2019Peel HuntReiterated RatingHoldGBX 62
11/12/2019Peel HuntReiterated RatingHoldGBX 62
11/12/2019Liberum CapitalReiterated RatingHoldGBX 76
11/5/2019Peel HuntReiterated RatingHold
10/22/2019Peel HuntReiterated RatingHold
10/15/2019Peel HuntReiterated RatingHold
10/7/2019Peel HuntReiterated RatingHold
10/1/2019Peel HuntReiterated RatingHold
9/17/2019Peel HuntReiterated RatingHold
9/10/2019Peel HuntReiterated RatingHold
8/27/2019Peel HuntReiterated RatingHold
8/9/2019Peel HuntReiterated RatingHold
7/9/2019Peel HuntReiterated RatingHold
7/2/2019Liberum CapitalReiterated RatingHold
7/2/2019Peel HuntReiterated RatingHold
6/25/2019Peel HuntReiterated RatingHold
6/17/2019Peel HuntBoost Price TargetHoldGBX 56 ➝ GBX 62
6/11/2019Peel HuntReiterated RatingHold
6/4/2019Peel HuntReiterated RatingHold
5/28/2019Peel HuntReiterated RatingHold
5/21/2019Peel HuntReiterated RatingHold
5/21/2019Liberum CapitalReiterated RatingHold
5/14/2019Peel HuntReiterated RatingHold
5/8/2019Peel HuntReiterated RatingHold
3/26/2019Peel HuntReiterated RatingHold
3/21/2019JPMorgan Chase & Co.Initiated CoverageNeutralGBX 60
3/12/2019Liberum CapitalReiterated RatingHold
2/8/2019Liberum CapitalDowngradeHold
1/22/2019Peel HuntReiterated RatingHold
1/22/2019Liberum CapitalReiterated RatingBuy
1/9/2019Liberum CapitalReiterated RatingBuy
12/17/2018Liberum CapitalReiterated RatingBuy
12/5/2018Liberum CapitalReiterated RatingBuy
11/22/2018Peel HuntReiterated RatingHold
11/22/2018Liberum CapitalReiterated RatingBuy
10/19/2018Liberum CapitalReiterated RatingBuy
10/5/2018Liberum CapitalReiterated RatingBuy
10/2/2018Peel HuntReiterated RatingHold
7/20/2018Liberum CapitalReiterated RatingBuy
7/5/2018Liberum CapitalReiterated RatingBuy
7/5/2018Peel HuntReiterated RatingHold
5/23/2018Liberum CapitalReiterated RatingBuy
5/23/2018Peel HuntReiterated RatingHold
4/5/2018Peel HuntReiterated RatingHold
2/1/2018Liberum CapitalLower Price TargetBuyGBX 68 ➝ GBX 66
1/18/2018Jefferies Financial GroupReiterated RatingBuyGBX 70
1/8/2018Liberum CapitalReiterated RatingBuyGBX 68
11/29/2017Jefferies Financial GroupInitiated CoverageBuyGBX 66
11/16/2017Peel HuntBoost Price TargetHoldGBX 55 ➝ GBX 57
11/16/2017Liberum CapitalReiterated RatingBuyGBX 68
11/10/2017Peel HuntReiterated RatingHoldGBX 55
10/2/2017Peel HuntReiterated RatingHold
10/2/2017Liberum CapitalReiterated RatingBuyGBX 68
8/7/2017Liberum CapitalReiterated RatingBuyGBX 68
8/1/2017Liberum CapitalReiterated RatingBuyGBX 68
7/18/2017Liberum CapitalReiterated RatingBuyGBX 68
6/28/2017Liberum CapitalBoost Price TargetBuyGBX 66 ➝ GBX 68
6/20/2017Peel HuntReiterated RatingHoldGBX 55
5/23/2017Peel HuntReiterated RatingHoldGBX 55
5/23/2017Liberum CapitalReiterated RatingBuyGBX 60
3/13/2017Liberum CapitalReiterated RatingBuyGBX 60
2/27/2017Liberum CapitalReiterated RatingBuyGBX 60
2/1/2017Liberum CapitalUpgradeBuyGBX 60
11/28/2016Liberum CapitalReiterated RatingHoldGBX 60
11/22/2016Liberum CapitalReiterated RatingHoldGBX 60
11/22/2016Peel HuntReiterated RatingHoldGBX 55
11/1/2016Liberum CapitalReiterated RatingHoldGBX 60
10/3/2016Liberum CapitalReiterated RatingHoldGBX 60
(Data available from 7/26/2016 forward)
Assura logo
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.
Read More

Today's Range

Now: GBX 77.15
Low: 77.10
High: 77.85

50 Day Range

MA: GBX 222.70
Low: 72.40
High: 7,440

52 Week Range

Now: GBX 77.15
Low: 70
High: 84

Volume

2,660,435 shs

Average Volume

5,860,996 shs

Market Capitalization

£2.06 billion

P/E Ratio

18.82

Dividend Yield

3.82%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Assura?

The following Wall Street sell-side analysts have issued stock ratings on Assura in the last twelve months: Berenberg Bank, Jefferies Financial Group Inc., Liberum Capital, Numis Securities Ltd, Peel Hunt, and Peel Hunt LLP.
View the latest analyst ratings for AGR.

What is the current price target for Assura?

6 Wall Street analysts have set twelve-month price targets for Assura in the last year. Their average twelve-month price target is GBX 83.83, suggesting a possible upside of 8.7%. Jefferies Financial Group Inc. has the highest price target set, predicting AGR will reach GBX 90 in the next twelve months. Liberum Capital has the lowest price target set, forecasting a price of GBX 75 for Assura in the next year.
View the latest price targets for AGR.

What is the current consensus analyst rating for Assura?

Assura currently has 5 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in AGR, but not buy more shares or sell existing shares.
View the latest ratings for AGR.

What other companies compete with Assura?

How do I contact Assura's investor relations team?

Assura's physical mailing address is The Brew House, Greenalls Avenue, WARRINGTON, WA4 6HL, United Kingdom. The real estate investment trust's listed phone number is +44-1925-420660. The official website for Assura is www.assuraplc.com.